RAD1 Antikörper (AA 77-275)
-
- Target Alle RAD1 Antikörper anzeigen
- RAD1 (Cell Cycle Checkpoint Protein RAD1 (RAD1))
-
Bindungsspezifität
- AA 77-275
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RAD1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purified by Protein A.
- Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 77 and 275 of Human RAD1
- Top Product
- Discover our top product RAD1 Primärantikörper
-
-
- Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
- Target
- RAD1 (Cell Cycle Checkpoint Protein RAD1 (RAD1))
- Andere Bezeichnung
- Rad1 (RAD1 Produkte)
- Synonyme
- HRAD1 antikoerper, REC1 antikoerper, zgc:56502 antikoerper, zgc:77779 antikoerper, RAD1 antikoerper, xrad1 antikoerper, DKFZp459H1127 antikoerper, RAD1 checkpoint DNA exonuclease antikoerper, RAD1 homolog (S. pombe) antikoerper, RAD1 antikoerper, Rad1 antikoerper, rad1 antikoerper
- Hintergrund
-
This gene encodes a component of a heterotrimeric cell cycle checkpoint complex, known as the 9-1-1 complex, that is activated to stop cell cycle progression in response to DNA damage or incomplete DNA replication.The 9-1-1 complex is recruited by RAD17 to affected sites where it may attract specialized DNA polymerases and other DNA repair effectors.Alternatively spliced transcript variants of this gene have been described.[provided by RefSeq]
Synonyms: HRAD1, REC1 - Molekulargewicht
- 32 kDa
- Gen-ID
- 5810
- NCBI Accession
- NM_002853, NP_002844
- Pathways
- M Phase
-